Meloxicam Completed Phase 3 Trials for Rheumatoid Arthritis, Juvenile Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00034853Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
NCT00279747A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)